Diabetes Care Devices Market Forecast to 2028

Growth Opportunities in Wearables for the Multiparametric Testing of Glucose and Lipids, AI-based Early Diagnosis Tools and Tests

The “Diabetes Care Devices, Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

This study provides a detailed overview of the global diabetes care device industry, which is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions.

The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, AI-equipped technology to enhance diabetes care and expand the customer base beyond patients with type 1 diabetes (T1D) to those with type 2 diabetes (T2D), prediabetes, and even those without diabetes. Companies are adopting novel business strategies that create steady revenue streams and ease patients’ financial burdens.

The study segments diabetes care devices into two main categories: glucose monitoring and insulin delivery. Glucose monitoring devices comprise self-monitoring of blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems, while insulin delivery devices comprise insulin pumps and insulin pens. The study also segments the industry according to diabetes type (T1D and T2D), examining the unique market dynamics of each.

The geographic scope includes North America, Europe, Asia-Pacific (APAC), the Middle East, Africa, and South Asia (MEASA), and Latin America. The study provides relevant forecast, sizing, and trend analyses across all segments. It examines the competitive landscape and highlights the key players and significant technologies making an impact in this space.

The study identifies the factors driving and restraining growth in each segment and analyzes the opportunities emerging from the changes in this industry for market players and stakeholders to leverage. The base year is 2023, and the forecast period is from 2024 to 2028.

Key Growth Opportunities

  • Insulin Pumps for T2D patients
  • Wearables for the Multiparametric Testing of Glucose and Lipids
  • Eco-friendly Insulin Pens
  • CGM for T1D Children and Adolescents in China
  • AI-based Early Diagnosis Tools and Tests

Key Topics Covered:

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation
  • Key Competitors
  • Growth Metrics
  • Distribution Channels
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast by Segment
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Revenue Share by Segment
  • Competitive Environment
  • Revenue Share
  • Revenue Share Analysis

Trends in the Diabetes Care Continuum

  • Global Diabetes Prevalence
  • New Business Models
  • Care Setting Trends
  • Eco-friendly Management
  • Metabolic Health
  • New Insulin Delivery Systems
  • AI Integration in Diabetes Care

T1D Opportunities

  • T1D Patient Journey
  • Children and Adolescents with T1D in China
  • Growth Opportunity: CGM for T1D Children and Adolescents in China
  • China: Market Analysis and Penetration Approach
  • Additional Ways to Address T1D Patient Needs

T2D Opportunities

  • T2D Patient Journey
  • Global T2D Prevalence
  • T2D: A Global Health Concern
  • Reimbursement for T2D
  • Opportunities in T2D Presented by GLP-1
  • Insulin Pump Growth Opportunities in T2D

Emerging Companies

  • Diabeloop’s DBLG1 Algorithm for Insulin Delivery
  • Decide Clinical Software’s GlucoTab

Growth Opportunity Analysis: SMBG

  • SMBG Growth Metrics
  • SMBG Growth Drivers
  • SMBG Growth Restraints
  • SMBG Revenue Forecast
  • SMBG Revenue Forecast by Region
  • SMBG Competitors
  • SMBG Forecast Analysis

Growth Opportunity Analysis: CGM

  • CGM Growth Metrics
  • CGM Growth Drivers
  • CGM Growth Restraints
  • CGM Revenue Forecast
  • CGM Revenue Forecast by Region
  • CGM Key Competitors
  • CGM Reimbursement Trends and Market Shifts
  • Diversifying CGM User Base
  • CGM Forecast Analysis

Growth Opportunity Analysis: Insulin Pens

  • Insulin Pen Growth Metrics
  • Insulin Pen Growth Drivers
  • Insulin Pen Growth Restraints
  • Insulin Pen Revenue Forecast
  • Insulin Pen Revenue Forecast by Region
  • Insulin Pen Key Competitors
  • Insulin Pen Reimbursement Trends and Market Shifts
  • Insulin Pen Forecast Analysis

Growth Opportunity Analysis: Insulin Pumps

  • Insulin Pump Growth Metrics
  • Insulin Pump Growth Drivers
  • Insulin Pump Growth Restraints
  • Insulin Pump Revenue Forecast
  • Insulin Pump Revenue Forecast by Region
  • Insulin Pump Key Competitors
  • Insulin Pump Reimbursement Trends and Market Shifts
  • Insulin Pump Forecast Analysis

For more information about this report visit here.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.